EPIGRAL

Epigral Share Price

₹1,928.65 +0.85 (0.04%)

21 Nov, 2024 14:22

SIP TrendupStart SIP in EPIGRAL

Start SIP

Performance

  • Low
  • ₹1,890
  • High
  • ₹1,943
  • 52 Week Low
  • ₹888
  • 52 Week High
  • ₹2,407
  • Open Price₹1,942
  • Previous Close₹1,928
  • Volume43,239

Investment Returns

  • Over 1 Month -12.89%
  • Over 3 Month + 3.57%
  • Over 6 Month + 50.55%
  • Over 1 Year + 113.22%
SIP Lightning

Smart Investing Starts Here Start SIP with Epigral for Steady Growth!

Invest Now

Epigral Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 28.3
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 8,320
  • P/B Ratio
  • 6.6
  • Average True Range
  • 127.29
  • EPS
  • 68.04
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -16.38
  • RSI
  • 41.57
  • MFI
  • 39.6

Epigral Financials

Epigral Technicals

EMA & SMA

Current Price
₹1,928.65
+ 0.85 (0.04%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹2,057.61
  • 50 Day
  • ₹2,044.15
  • 100 Day
  • ₹1,904.29
  • 200 Day
  • ₹1,665.97

Resistance and Support

1957.25 Pivot Speed
  • R3 2,110.45
  • R2 2,069.20
  • R1 1,998.50
  • S1 1,886.55
  • S2 1,845.30
  • S3 1,774.60

What's your outlook on Epigral?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

EpigraL Ltd. is a prominent manufacturer of high-performance specialty chemicals and coatings in India. The company specializes in producing epoxy resins, adhesives, and surface treatment products, catering to various industries including automotive, construction, and electronics.

Epigral Ltd has an operating revenue of Rs. 2,273.41 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of 15% is great, ROE of 15% is good. The company has a reasonable debt to equity of 39%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 23% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 76 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Epigral Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-09 Quarterly Results
2024-08-14 To consider Fund Raising
2024-07-24 Quarterly Results
2024-04-22 Audited Results & Final Dividend
2024-01-24 Quarterly Results
Date Purpose Remarks
2024-07-02 FINAL Rs.5.00 per share(50%)Final Dividend
2023-06-20 FINAL Rs.2.50 per share(25%)Final Dividend
2023-02-01 INTERIM Rs.2.50 per share(25%)Interim Dividend

Epigral F&O

Epigral Shareholding Pattern

71.58%
1.04%
2.1%
18.51%
6.77%

About Epigral

  • NSE Symbol
  • EPIGRAL
  • BSE Symbol
  • 543332
  • Chairman & Managing Director
  • Mr. Maulik Jayantibhai Patel
  • ISIN
  • INE071N01016

Similar Stocks to Epigral

Epigral FAQs

Epigral share price is ₹1,928 As on 21 November, 2024 | 14:08

The Market Cap of Epigral is ₹8320.4 Cr As on 21 November, 2024 | 14:08

The P/E ratio of Epigral is 28.3 As on 21 November, 2024 | 14:08

The PB ratio of Epigral is 6.6 As on 21 November, 2024 | 14:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23